UBS AM’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.59M | Buy |
|
|||||
|
2025
Q1 | $1.19M | Sell |
|
|||||
|
2024
Q4 | $2.82M | Sell |
|
|||||
|
2024
Q3 | $2.28M | Sell |
|
|||||
|
2024
Q2 | $1.47M | Buy |
|
|||||
|
2024
Q1 | $802K | Buy |
|
|||||
|
2023
Q4 | $894K | Hold |
|
|||||
|
2023
Q3 | $889K | Buy |
|
|||||
|
2023
Q2 | $1.99M | Hold |
|
|||||
|
2023
Q1 | $1.99M | Buy |
|
|||||
|
2022
Q4 | $1.34M | Buy |
|
|||||
|
2022
Q3 | $1.54M | Sell |
|
|||||
|
2022
Q2 | $1.6M | Sell |
|
|||||
|
2022
Q1 | $1.73M | Buy |
|
|||||
|
2021
Q4 | $1.96M | Buy |
|
|||||
|
2021
Q3 | $1.26M | Sell |
|
|||||
|
2021
Q2 | $781K | Buy |
|
|||||
|
2021
Q1 | $1.23M | Buy |
|
|||||
|
2020
Q4 | $1.05M | Hold |
|
|||||
|
2020
Q3 | $714K | Buy |
|
|||||
|
2020
Q2 | $688K | Buy |
|
|||||
|
2020
Q1 | $441K | Sell |
|
|||||
|
2019
Q4 | $443K | Buy |
|
|||||
|
2019
Q3 | $351K | Buy |
|
|||||
|
2019
Q2 | $293K | Sell |
|
|||||
|
2019
Q1 | $538K | Buy |
|
|||||
|
2018
Q4 | $208K | Sell |
|
|||||
|
2018
Q3 | $485K | Hold |
|
|||||
|
2018
Q2 | $460K | Buy |
|
|||||
|
2018
Q1 | $202K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $436K | Hold |
|
|||||
|
2016
Q2 | $347K | Buy |
|
|||||
|
2016
Q1 | $156K | Sell |
|
|||||
|
2015
Q4 | $235K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $348K | Buy |
|